Is Alnylam Pharmaceuticals, Inc. stock a buy or sell right now?

Alnylam Pharmaceuticals, Inc. currently trades in a Neutral range, with momentum and trend indicators showing no clear direction.

What is Alnylam Pharmaceuticals, Inc.’s RSI?

RSI is 47.68, showing balanced momentum within the normal range.

What does MACD indicate for DUL.DE?

MACD at -0.90 shows bearish pressure, with downside momentum building.

What are Alnylam Pharmaceuticals, Inc.’s key support and resistance levels?

Support sits around $264.48, while resistance is near $288.91.

Alnylam Pharmaceuticals, Inc.

DUL.DE•XETRA

Healthcare

Biotechnology

€276.30

€-7.90(-2.78%)

German Market is Open • 16:54

Alnylam Pharmaceuticals, Inc. (DUL.DE) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Alnylam Pharmaceuticals, Inc. (XETRA:DUL.DE).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

DUL.DE Technical Analysis Summary

Alnylam Pharmaceuticals, Inc. stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral

Momentum:Neutral to Bearish (RSI: 47.68)

Trend Strength:Weak (ADX: 15.54)

Volatility:Medium (ATR: 8.14)

Support/Resistance:$264.48 – $288.91 (Bollinger Bands)

This mix signals that Alnylam Pharmaceuticals, Inc. is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 47.68

Bearish

Below midpoint indicates downward pressure.

Stochastic %K: 78.67

Bullish

Buying momentum building without extremes.

Williams %R: -43.73

Neutral

Balanced market without strong signals.

Rate of Change (ROC): 0.44

Neutral

Price change is minimal.

Takeaway:Alnylam Pharmaceuticals, Inc. shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: -0.90

Bearish

Bearish, trend momentum is strengthening to the downside.

ADX: 15.54

Weak

Weak trend, market trading sideways.

ATR (14): 8.14

Rising

Rising volatility, market activity increasing.

CCI (14): 27.57

Bullish

Bullish, momentum building upward.

Takeaway:Alnylam Pharmaceuticals, Inc. shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators

Bollinger Bands

Upper Band

$288.91

Middle Band (SMA 20)

$276.69

Lower Band

$264.48

Current Position

Within Bands

Takeaway:Alnylam Pharmaceuticals, Inc. trades closer to support, showing weaker momentum within bands.

Keltner Channels

Upper Channel

$294.31

Middle Line (EMA 20)

$278.03

Lower Channel

$261.75

Squeeze Status

Squeeze On

Takeaway:Alnylam Pharmaceuticals, Inc. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis

On-Balance Volume702.00

Money Flow Index34.21Bearish, selling pressure outweighs inflows.

Relative Vigor Index48.75Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:DUL.DE shows bearish money flow, with sellers dominating volume and vigor.

Technical Trading Signals Summary

Based on the current technical analysis of Alnylam Pharmaceuticals, Inc., here are the key trading signals and recommendations:

Bullish Signals

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Technical indicators for Alnylam Pharmaceuticals, Inc. are mixed, suggesting a Hold or wait-and-see approach.